chr6-97165445-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001350599.2(MMS22L):c.3022G>A(p.Val1008Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,611,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001350599.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MMS22L | NM_001350599.2 | c.3022G>A | p.Val1008Met | missense_variant | 21/25 | ENST00000683635.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MMS22L | ENST00000683635.1 | c.3022G>A | p.Val1008Met | missense_variant | 21/25 | NM_001350599.2 | P1 | ||
MMS22L | ENST00000275053.8 | c.3022G>A | p.Val1008Met | missense_variant | 21/25 | 2 | P1 | ||
MMS22L | ENST00000369251.6 | c.2902G>A | p.Val968Met | missense_variant | 19/23 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 151860Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000132 AC: 33AN: 249490Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 134872
GnomAD4 exome AF: 0.000178 AC: 260AN: 1460112Hom.: 0 Cov.: 33 AF XY: 0.000179 AC XY: 130AN XY: 726412
GnomAD4 genome AF: 0.000125 AC: 19AN: 151860Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74138
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | The c.3022G>A (p.V1008M) alteration is located in exon 21 (coding exon 20) of the MMS22L gene. This alteration results from a G to A substitution at nucleotide position 3022, causing the valine (V) at amino acid position 1008 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at